S1235-118

Introduced

To establish an awareness campaign related to the lethality of fentanyl and fentanyl-contaminated drugs, to establish a Federal Interagency Work Group on Fentanyl Contamination of Illegal Drugs, and to provide community-based coalition enhancement grants to mitigate the effects of drug misuse.

118th Congress Introduced Apr 20, 2023

Summary

What This Bill Does

The bill provides awareness campaigns Section 102 of the Comprehensive Addiction and Recovery Act of 2016 (Public Law 114–198) is amended— in the section heading, by inserting relating to opioids after campaigns, provides awareness campaign related to lethality of fentanyl and fentanyl-contaminated drugs, and requires federal Interagency Work Group on Fentanyl Contamination of Illegal Drugs Title I of the Comprehensive Addiction and Recovery Act of 2016 (Public Law 114–198), as amended by section 2(b), is further amended. It relies on definition changes, compliance mandates, appropriations, and grants. The main policy areas are Education, Healthcare, Agriculture, and Environment.

Who Benefits and How

Patients and health care consumers affected by the bill could gain revenue opportunities, Educational institutions and students affected by the bill could gain revenue opportunities, and Cannabis businesses, researchers, or patients affected by the bill could gain revenue opportunities.

Who Bears the Burden and How

Federal, state, or local agencies responsible for implementing the clause would take on compliance duties, Tribal governments and members affected by the bill would take on compliance duties, and Patients and health care consumers affected by the bill would take on compliance duties.

Key Provisions

  • Provides awareness campaigns Section 102 of the Comprehensive Addiction and Recovery Act of 2016 (Public Law 114–198) is amended— in the section heading, by inserting relating to opioids after campaigns.
  • Provides awareness campaign related to lethality of fentanyl and fentanyl-contaminated drugs.
  • Requires federal Interagency Work Group on Fentanyl Contamination of Illegal Drugs Title I of the Comprehensive Addiction and Recovery Act of 2016 (Public Law 114–198), as amended by section 2(b), is further amended...
  • Requires federal Interagency Work Group on Fentanyl Contamination of Illegal Drugs.
  • Creates community-based coalition enhancement grants to address local drug crises Section 103(i) of the Comprehensive Addiction and Recovery Act of 2016 (21 U.S.C. 1536(i)) is amended by striking 2017 through 2021...

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.

At a Glance

What This Bill Does

The bill provides awareness campaigns Section 102 of the Comprehensive Addiction and Recovery Act of 2016 (Public Law 114–198) is amended— in the section heading, by inserting relating to opioids after campaigns, provides awareness campaign related to lethality of fentanyl and fentanyl-contaminated drugs, and requires federal Interagency Work Group on Fentanyl Contamination of Illegal Drugs Title I of the Comprehensive Addiction and Recovery Act of 2016 (Public Law 114–198), as amended by section 2(b), is further amended.

Key Policy Areas

Education, Healthcare, Agriculture, Environment

Primary Purpose

The bill provides awareness campaigns Section 102 of the Comprehensive Addiction and Recovery Act of 2016 (Public Law 114–198) is amended— in the section heading, by inserting relating to opioids after campaigns, provides awareness campaign related to lethality of fentanyl and fentanyl-contaminated drugs, and requires federal Interagency Work Group on Fentanyl Contamination of Illegal Drugs Title I of the Comprehensive Addiction and Recovery Act of 2016 (Public Law 114–198), as amended by section 2(b), is further amended.

Policy Domains

Education Healthcare Agriculture Environment

Whole bill

Identified Gains
  • Patients and health care consumers affected by the bill
  • Educational institutions and students affected by the bill
  • Cannabis businesses, researchers, or patients affected by the bill
  • Lobbyists, political organizations, and disclosure users affected by the bill
  • Environmental and public health interests affected by the bill
Model: codex-gpt-5:bulk-repair | Version: bill_summary_v2 | Source: is
Patients and health care consumers affected by the bill: , , , ,
Educational institutions and students affected by the bill: , , ,
Environmental and public health interests affected by the bill: ,
Cannabis businesses, researchers, or patients affected by the bill: , , ,
Lobbyists, political organizations, and disclosure users affected by the bill: , ,
Identified Costs
  • Federal, state, or local agencies responsible for implementing the clause
  • Tribal governments and members affected by the bill
  • Patients and health care consumers affected by the bill
  • Environmental and public health interests affected by the bill
  • Educational institutions and students affected by the bill
Model: codex-gpt-5:bulk-repair | Version: bill_summary_v2 | Source: is
Tribal governments and members affected by the bill: ,
Patients and health care consumers affected by the bill: ,
Educational institutions and students affected by the bill: ,
Environmental and public health interests affected by the bill: ,
Federal, state, or local agencies responsible for implementing the clause: , , , , ,

Legislative Progress

Introduced
Introduced Committee Passed
Apr 20, 2023

Ms. Murkowski (for herself, Mrs. Feinstein, Mr. Sullivan, Ms. Hassan, …

Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Education Healthcare Agriculture Environment

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology